INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Core Insights - INVO Fertility, Inc. will participate in the Lytham Partners Fall 2025 Investor Conference, hosting a webcast presentation and one-on-one meetings with investors on September 30, 2025 [1][2][3] Company Overview - INVO Fertility is a healthcare services company focused on expanding access to assisted reproductive technology (ART) through the establishment, acquisition, and operation of fertility clinics [4] - The company's primary strategy includes building and operating "INVO Centers" that offer the intravaginal culture (IVC) procedure using the proprietary INVOcell medical device, which allows fertilization and early embryo development to occur in vivo within the woman's body [4] - INVO Fertility currently operates two INVO Centers and one IVF clinic in the United States, and it also sells and distributes the INVOcell device to third-party fertility clinics [4] - The IVC procedure is designed to provide a more connected, intimate, and affordable experience compared to traditional ART treatments, potentially delivering comparable results at a lower cost than traditional IVF [4]